Role of Peripheral and Central Insulin Resistance in Neuropsychiatric Disorders
Journal of Clinical Medicine · 03.11.2024 · 13 (21) · 6607
DOI: 10.3390/jcm13216607 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.11.2024. Verfasst von Kannayiram Alagiakrishnan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Insulin acts on different organs, including the brain, which helps it regulate energy metabolism. Insulin signaling plays an important role in the function of different cell types. In this review, we have summarized the key roles of insulin and insulin receptors in healthy brains and in different brain disorders. Insulin signaling, as well as insulin resistance (IR), is a major contributor in the regulation of mood, behavior, and cognition. Recent evidence showed that both peripheral and central insulin resistance play a role in the pathophysiology, clinical presentation, and management of neuropsychiatric disorders like Cognitive Impairment/Dementia, Depression, and Schizophrenia. Many human studies point out Insulin Resistance/Metabolic Syndrome can increase the risk of dementia especially Alzheimer’s dementia (AD). IR has been shown to play a role in AD development but also in its progression. This review article discusses the pathophysiological pathways and mechanisms of insulin resistance in major neuropsychiatric disorders. The extent of insulin resistance can be quantified using IR biomarkers like insulin levels, HOMA-IR index, and Triglyceride glucose–body mass index (TyG–BMI) levels. IR has been shown to precede neurodegeneration. Human trials showed current treatment with certain antidiabetic drugs, as well as life style management, like weight loss and exercise for IR, have shown promise in the management of cognitive/neuropsychiatric disorders. This may pave the pathway to the development of new therapeutic approaches to these challenging disorders of dementia and psychiatric diseases. Recent clinical trials are showing some encouraging evidence for these pharmacological and nonpharmacological approaches for IR in psychiatric and cognitive disorders, even though more research is needed to apply this evidence into clinical practice. Early identification and management of IR may help as a strategy to potentially alter neuropsychiatric disorders onset as well as its progression
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada.
- Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada.
ORCID-Profile: Kannayiram Alagiakrishnan, Tyler Halverson
Zitieren
APA
Alagiakrishnan, K., & Halverson, T. (2024). Role of Peripheral and Central Insulin Resistance in Neuropsychiatric Disorders. Journal of Clinical Medicine, 13(21), 6607. https://doi.org/10.3390/jcm13216607
Vancouver
Alagiakrishnan K, Halverson T. Role of Peripheral and Central Insulin Resistance in Neuropsychiatric Disorders. Journal of Clinical Medicine. 2024;13(21):6607. doi:10.3390/jcm13216607
BibTeX
@article{Alagiakrishnan2024,
author = {Alagiakrishnan, Kannayiram and Halverson, Tyler},
title = {Role of Peripheral and Central Insulin Resistance in Neuropsychiatric Disorders},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {21},
pages = {6607},
doi = {10.3390/jcm13216607}
}
EUVIMED